Cryoport, Inc.·4

Mar 11, 7:00 PM ET

STEFANOVICH ROBERT 4

4 · Cryoport, Inc. · Filed Mar 11, 2025

Insider Transaction Report

Form 4
Period: 2025-03-09
STEFANOVICH ROBERT
CFO, Treasurer and Secretary
Transactions
  • Exercise/Conversion

    Restricted Stock Rights

    2025-03-092,6670 total
    Common Stock (2,667 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-09+2,667184,334 total
  • Sale

    Common Stock

    2025-03-10$4.88/sh1,256$6,128183,078 total
Footnotes (3)
  • [F1]Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
  • [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
  • [F3]The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

Documents

1 file
  • 4
    tm258882-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT